三个皮匠报告
最新
报告分类 研搜
BETA
政策库
自研报告
new
入驻
搜索
您的当前位置：首页 > 行业数据 > A400与第一代RET抑制剂治疗晚期RET+NSCLC疗效对比
图片属性
图片格式：PNG 图片大小：72KB 图片尺寸：1749*579
同报告图片
 / 4
A400与第一代RET抑制剂治疗晚期RET+NSCLC疗效对比_第1页
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
A400与第一代RET抑制剂治疗晚期RET+NSCLC疗效对比_第2页
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
A400与第一代RET抑制剂治疗晚期RET+NSCLC疗效对比_第3页
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
A400与第一代RET抑制剂治疗晚期RET+NSCLC疗效对比_第4页
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
A400与第一代RET抑制剂治疗晚期RET+NSCLC疗效对比_第5页
所属报告： 科伦博泰生物-公司研究报告：ADC平台技术优势突出核心品种TROP2 ADC获批上市-241208（32页）.pdf
打包全文图表

相关数据

最新数据
全行业研究报告分享下载平台
  • 0731-84720580
  • 商务合作：really158d
关于我们
更多
关于我们
三个皮匠报告微信公众号
三个皮匠报告微信小程序
扫码咨询网站充值下载问题
copyright@2008-2013 长沙景略智创信息技术有限公司版权所有        网站备案/许可证号：湘B2-20190120 | 工信部备案号：湘ICP备17000430号-2 | 公安备案号：湘公网安备43010402001071号
客服
商务合作
小程序
服务号
折叠